Cargando…

Tumor Necrosis Factor-alpha Antibodies in Fistulizing Crohn's Disease: An Updated Systematic Review and Meta-analysis

Medical treatment for fistulizing Crohn's disease (FCD) is changing rapidly over the time by the introduction of novel therapeutic medicines, while no global consensus is available. This study aims to accomplish a systematic review and meta-analysis on the efficacy of tumor necrosis factor-alph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaboli, Pardis, Abdollahi, Mohammad, Mozaffari, Shilan, Nikfar, Shekoufeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632933/ https://www.ncbi.nlm.nih.gov/pubmed/29026838 http://dx.doi.org/10.4103/jrpp.JRPP_17_46

Ejemplares similares

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients
por: Mozaffari, Shilan, et al.
Publicado: (2014)

Is Certolizumab Pegol Safe and Effective in the Treatment of Patients with Moderate to Severe Crohn’s Disease? A Meta-analysis of Controlled Clinical Trials
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

Potential Vaccines for Treating Crohn's Disease
por: Rostami-Nejad, Mohammad, et al.
Publicado: (2020)

Increasing the risk of spontaneous abortion and major malformations in newborns following use of serotonin reuptake inhibitors during pregnancy: A systematic review and updated meta-analysis
por: Nikfar, Shekoufeh, et al.
Publicado: (2012)

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
por: Rezaie, Ali, et al.
Publicado: (2010)

Fistulizing Crohn’s Disease
por: Scharl, Michael, et al.
Publicado: (2017)

Long‐term outcomes of anti‐tumor necrosis factor therapy and surgery in nonperianal fistulizing Crohn's disease
por: Vuyyuru, Sudheer K, et al.
Publicado: (2021)

Vedolizumab for perianal fistulizing Crohn’s disease: systematic review and meta-analysis
por: Ayoub, Fares, et al.
Publicado: (2022)

Pegylated versus non-pegylated interferon beta 1a in patients with relapsing-remitting multiple sclerosis: A cost-effectiveness analysis
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2018)

Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy
por: Papamichael, Konstantinos, et al.
Publicado: (2017)

A meta-analysis on the efficacy and tolerability of natalizumab in relapsing multiple sclerosis
por: Nikfar, Shekoufeh, et al.
Publicado: (2010)

A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2011)

Pathogenesis of Fistulating Crohn’s Disease: A Review
por: McGregor, Colleen Georgette Chantelle, et al.
Publicado: (2022)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Current opinion on treatment of inflammatory bowel disease in pregnant women
por: Salari, Pooneh, et al.
Publicado: (2012)

Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021)

Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis
por: Lee, Tanya, et al.
Publicado: (2019)

Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018)

Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022)

Ileal Crohn's disease fistulating into a Meckel's diverticulum
por: Zammit, Andrew Philip, et al.
Publicado: (2022)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Spontaneous fistulization of walled‐off pancreatic necrosis into the colon
por: Khan, Tanveer, et al.
Publicado: (2020)

Sweet’s syndrome and fistulizing Crohn’s disease: A case report
por: Siedlikowski, Stefan T, et al.
Publicado: (2019)

Dysbiosis in a canine model of human fistulizing Crohn’s disease
por: Maldonado-Contreras, Ana, et al.
Publicado: (2020)

Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)

Establishing a rabbit model of perianal fistulizing Crohn’s disease
por: Lu, Shuang-Shuang, et al.
Publicado: (2022)

A Comprehensive Review of Clinical Trials on EGFR Inhibitors Such as Cetuximab and Panitumumab as Monotherapy and in Combination for Treatment of Metastatic Colorectal Cancer
por: Yazdi, Mohammad Hossein, et al.
Publicado: (2015)

Cephalic Duodenopancreatectomy for Hyperalgic Duodenal Crohn's Disease Fistulized in the Pancreatic Gland
por: Guellouz, Sabra, et al.
Publicado: (2014)

Factors associated with surgery in patients with intra-abdominal fistulizing Crohn's disease
por: Yaari, Shaul, et al.
Publicado: (2016)

Analysis of Risk Factors for Anorectal Stenosis of Perianal Fistulizing Crohn’s Disease
por: Xu, MinMin, et al.
Publicado: (2020)

Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era
por: Lee, Tanya, et al.
Publicado: (2020)

Perianal fistulizing Crohn's disease and overall risk of cancer: No red flag
por: McLellan, Paul, et al.
Publicado: (2023)

Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
por: Ma, Ye, et al.
Publicado: (2023)

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries
por: Soleymani, Fatemeh, et al.
Publicado: (2018)

Prognostic factors affecting outcomes in fistulating perianal Crohn’s disease: a systematic review
por: Braithwaite, G. C., et al.
Publicado: (2017)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis
por: Kawalec, Paweł, et al.
Publicado: (2013)

Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging
por: Yan, Xiaohan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_53vqla9neugvav3sarocgrfb7h